|
1
|
Dountsis A, Zsis C, Karagianni E and
Dahabreh J: Primary malignant melanoma of the lung: A case report.
World J Surg Oncol. 1:26–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Q, Zhang R and Liu D: Long non-coding
RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma
progression through targeting miR-1224-5p. Exp Ther Med.
17:857–862. 2019.PubMed/NCBI
|
|
3
|
Slominski A, Tobin DJ, Shibahara S and
Wortsman J: Melanin pigmentation in mammalian skin and its hormonal
regulation. Physiol Rev. 84:1155–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang L, Pei J, Li C, Zhang P, Zhou D, Du
W, Liu X and Jiang C: Incidence and metastasis of cutaneous
malignant melanoma with respect to ABO blood groups: A
case-controlled study in northeast of China. PLoS One.
9:e880962014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sample A and He YY: Mechanisms and
prevention of UV-induced melanoma. Photodermatol Photoimmunol
Photomed. 34:13–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khan AQ, Travers JB and Kemp MG: Roles of
UVA radiation and DNA damage responses in melanoma pathogenesis.
Environ Mol Mutagen. 59:438–460. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miura K and Green AC: Dietary Antioxidants
and Melanoma: Evidence from Cohort and Intervention Studies. Nutr
Cancer. 67:867–876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee SJ, Lee KB, Son YH, Shin J, Lee JH,
Kim HJ, Hong AY, Bae HW, Kwon MA, Lee WJ, et al: Transglutaminase 2
mediates UV-induced skin inflammation by enhancing inflammatory
cytokine production. Cell Death Dis. 8:e31482017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Slominski AT, Brozyna AA, Zmijewski MA,
Jóźwicki W, Jetten AM, Mason RS, Tuckey RC and Elmets CA: Vitamin D
signaling and melanoma: Role of vitamin D and its receptors in
melanoma progression and management. Lab Invest. 97:706–724. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao D, Barry S, Kmetz D, Egger M, Pan J,
Rai SN, Qu J, McMasters KM and Hao H: Melanoma cell-derived
exosomes promote epithelial-mesenchymal transition in primary
melanocytes through paracrine/autocrine signaling in the tumor
microenvironment. Cancer Lett. 376:318–327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giavina-Bianchi MH, Giavina-Bianchi PF
Junior and Festa C Neto: Melanoma: Tumor microenvironment and new
treatments. An Bras Dermatol. 92:156–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Slominski AT and Carlson JA: Melanoma
resistance: A bright future for academicians and a challenge for
patient advocates. Mayo Clin Proc. 89:429–433. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karimkhani C, Green AC, Nijsten T,
Weinstock MA, Dellavalle RP, Naghavi M and Fitzmaurice C: The
global burden of melanoma: Results from the Global burden of
disease study 2015. Br J Dermatol. 177:134–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Whiteman DC, Green AC and Olsen CM: The
growing burden of invasive melanoma: Projections of incidence rates
and numbers of new cases in six susceptible populations through
2031. J Invest Dermatol. 136:1161–1171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JS, Jeong TY, Cho CK, Lee YW and Yoo
HS: Antitumor effect of skin of venenum bufonis in a NCIH460 tumor
regression model. J Acupunct Meridian Stud. 3:181–187. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng LJ, Wang LH, Peng CK, Li YB, Huang
MH, Chen MF, Lei XP, Qi M, Cen Y, Ye WC, et al: Fibroblast
activation protein α activated tripeptide bufadienolide antitumor
prodrug with reduced cardiotoxicity. J Med Chem. 60:5320–5333.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang H, Li J, Cao Y, Liu T, Shi S and
Chen W: Bufadienolides from venenum bufonis inhibit mTOR-mediated
cyclin D1 and retinoblastoma protein leading to arrest of cell
cycle in cancer cells. Evid Based Complement Alternat Med.
2018:32474022018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amaral LS, Martins Ferreira J, Predes D,
Abreu JG, Noël F and Quintas LEM: Telocinobufagin and marinobufagin
produce different effects in LLC-PK1 cells: A case of functional
selectivity of bufadienolides. Int J Mol Sci. 19(pii): E27692018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sheng X, Zhu P, Qin J and Li Q: The
biological role of autophagy in regulating and controlling the
proliferation of liver cancer cells induced by bufalin. Oncol Rep.
39:2931–2941. 2018.PubMed/NCBI
|
|
20
|
Liu M, Feng LX, Sun P, Liu W, Wu WY, Jiang
BH, Yang M, Hu LH, Guo DA and Liu X: A novel bufalin derivative
exhibited stronger apoptosis-inducing effect than bufalin in A549
lung cancer cells and lower acute toxicity in mice. PLoS One.
11:e01597892016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Zhang X and Zhang J: MiR-129-5p
inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen
peroxide via the PI3K/AKT/mTOR signaling pathway by targeting
ATG14. Biochem Biophys Res Commun. 506:272–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng Q, Yau LF, Lu JG, Wu ZZ, Zhang BX,
Wang JR and Jiang ZH: Chemical profiling and cytotoxicity assay of
bufadienolides in toad venom and toad skin. J Ethnopharmacol.
187:74–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berger MF and Garraway LA: Applications of
genomics in melanoma oncogene discovery. Hematol Oncol Clin North
Am. 23:397–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui Y, Zhang Z, Zhang B, Zhao L, Hou C,
Zeng Q, Nie J, Yu J, Zhao Y, Gao T, et al: Excessive apoptosis and
disordered autophagy flux contribute to the neurotoxicity induced
by high iodine in Sprague-Dawley rat. Toxicol Lett. 297:24–33.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chou HY, Chueh FS, Ma YS, Wu RS, Liao CL,
Chu YL, Fan MJ, Huang WW and Chung JG: Bufalin induced apoptosis in
SCC-4 human tongue cancer cells by decreasing Bcl-2 and increasing
Bax expression via the mitochondria-dependent pathway. Mol Med Rep.
16:7959–7966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zaman S, Wang R and Gandhi V: Targeting
the apoptosis pathway in hematologic malignancies. Leuk Lymphoma.
55:1980–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yun CW and Lee SH: The roles of autophagy
in cancer. Int J Mol Sci. 19(pii): E34662018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Radogna F, Dicato M and Diederich M:
Cancer-type-specific crosstalk between autophagy, necroptosis and
apoptosis as a pharmacological target. Biochem Pharmacol. 94:1–11.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jena KK, Kolapalli SP, Mehto S, Nath P,
Das B, Sahoo PK, Ahad A, Syed GH, Raghav SK, Senapati S, et al:
TRIM16 controls assembly and degradation of protein aggregates by
modulating the p62-NRF2 axis and autophagy. EMBO J. 37(pii):
e983582018.PubMed/NCBI
|
|
30
|
Niklaus M, Adams O, Berezowska S, Zlobec
I, Graber F, Slotta-Huspenina J, Nitsche U, Rosenberg R, Tschan MP
and Langer R: Expression analysis of LC3B and p62 indicates intact
activated autophagy is associated with an unfavorable prognosis in
colon cancer. Oncotarget. 8:54604–54615. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sophia J, Kowshik J, Dwivedi A, Bhutia SK,
Manavathi B, Mishra R and Nagini S: Nimbolide, a neem limonoid
inhibits cytoprotective autophagy to activate apoptosis via
modulation of the PI3K/Akt/GSK-3β signalling pathway in oral
cancer. Cell Death Dis. 9:10872018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun YZ, Cai N and Liu NN: Celecoxib
down-regulates the hypoxia-induced expression of HIF-1α and VEGF
through the PI3K/AKT pathway in retinal pigment epithelial cells.
Cell Physiol Biochem. 44:1640–1650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng H, Cheng X, Kuang J, Chen L, Yuen S,
Shi M, Liang J, Shen B, Jin Z, Yan J and Qiu W: Apatinib-induced
protective autophagy and apoptosis through the AKT-mTOR pathway in
anaplastic thyroid cancer. Cell Death Dis. 9:10302018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan YP, Liu P, Xue WK, Zhao WJ and Pan HC:
Trimebutine promotes Glioma cell apoptosis as a potential
anti-tumor agent. Front Pharmacol Front Pharmacol. 9:6642018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen S, Zhang Y, Wang Z, Liu R and Gong X:
Bufalin induces the interplay between apoptosis and autophagy in
glioma cells through endoplasmic reticulum stress. Int J Biol Sci.
10:212–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A,
Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX and Ye WC:
Arenobufagin, a natural bufadienolide from toad venom, induces
apoptosis and autophagy in human hepatocellular carcinoma cells
through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis.
34:1331–1342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim SJ, Kim JH, Jung HS, Lee TJ, Lee KM
and Chang IH: Phosphorylated p70S6K in noninvasive low-grade
urothelial carcinoma of the bladder: Correlation with tumor
recurrence. Asian J Androl. 16:611–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaidanovich-Beilin O and Woodgett JR:
GSK-3: Functional Insights from Cell Biology and Animal Models.
Front Mol Neurosci. 4:402011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Q, Zheng M, Yin Y and Zhang W:
Ghrelin stimulates hepatocyte proliferation via regulating cell
cycle through GSK3β/B-catenin signaling pathway. Cell Physiol
Biochem. 50:1698–1710. 2018. View Article : Google Scholar : PubMed/NCBI
|
